Fused heterocyclic kinase inhibitors
In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
12.01.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases. |
---|---|
AbstractList | In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases. |
Author | ZHEN-WEI CAI TRAM N. HUYNH KYOUNG S. KIM ROBERT M. BORZILLERI WAYNE VACCARO XIAO TAO CHEN ZHONG CHEN |
Author_xml | – fullname: ZHEN-WEI CAI – fullname: ROBERT M. BORZILLERI – fullname: WAYNE VACCARO – fullname: XIAO TAO CHEN – fullname: TRAM N. HUYNH – fullname: ZHONG CHEN – fullname: KYOUNG S. KIM |
BookMark | eNrjYmDJy89L5WRQcSstTk1RyEgtSS3KT65MzslMVsjOzEssTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGpkZmQMLM0dCYOFUArdMpmA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2005260056A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2005260056A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:57:40 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2005260056A13 |
Notes | Application Number: AU20050260056 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060112&DB=EPODOC&CC=AU&NR=2005260056A1 |
ParticipantIDs | epo_espacenet_AU2005260056A1 |
PublicationCentury | 2000 |
PublicationDate | 20060112 |
PublicationDateYYYYMMDD | 2006-01-12 |
PublicationDate_xml | – month: 01 year: 2006 text: 20060112 day: 12 |
PublicationDecade | 2000 |
PublicationYear | 2006 |
RelatedCompanies | BRISTOL-MYERS SQUIBB COMPANY |
RelatedCompanies_xml | – name: BRISTOL-MYERS SQUIBB COMPANY |
Score | 2.6357477 |
Snippet | In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Fused heterocyclic kinase inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060112&DB=EPODOC&locale=&CC=AU&NR=2005260056A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTYHtumB1bSuQYphkq5JalKibqJhqqluarK5uaVhmhEolYBWW_iZeYSaeEWYRjAx5MD2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1eO8YmFyN1FycbF0D_F38ndWcnYE9STW_IPCJm6Cz2E3NHIF9JVZgQ9oclB9cw5xA-1IKkCsVN0EGtgCgeXklQgxMqXnCDJzOsLvXhBk4fKFT3kAmNPcVizCouJUWp6YoZIBWsOQnVyYDnaqQnZkHrIcUMvMyMpMyQTfniDIou7mGOHvoAq2Lh_su3jEU2W3GYgwswH5_qgSDQlqScUqipUkysKuYZGJimZaUaAxsL5kkm5lZmpumGqVIMsjgM0kKv7Q0AxdsNMHQSIaBpaSoNFUWWL-WJMmBgwUALAh9Ig |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQVH34q2TVv6MGTrB1W3bkgnextNmrKidMN2iP-9l7LOPe0tJJAv7nL3S-5-AegyC316NNPKU6JShXAaK7HKDYUzy7LVVBNSIqItQjOYkteZMWvAV50LU_GE_lTkiKhRDPW9rM7r1f8lllvFVhaPNMOq5bMf9Vx5i45RXDXZHfS8ydgdO7LjIJKUw_eKcVNwsRtmH7HSATrZltAH72Mg8lJWu0bFP4HDCfaXl6fQ4HkbWk7991objkabJ28sbrSvOIOuvy54Ii1EBMuS_TKcqvSZ5WiHpCxfZDQTP-ecw4PvRU6g4HDz7erm_enu3PQLaCLu55cgpVRPYpswhIqUEDulsY7-EmGmaVsG15Ir6Ozr6Xp_8z20gmg0nA9fwrcbOK5vFlStA83ye81v0daW9K7aoj81h4AV |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Fused+heterocyclic+kinase+inhibitors&rft.inventor=ZHEN-WEI+CAI&rft.inventor=ROBERT+M.+BORZILLERI&rft.inventor=WAYNE+VACCARO&rft.inventor=XIAO+TAO+CHEN&rft.inventor=TRAM+N.+HUYNH&rft.inventor=ZHONG+CHEN&rft.inventor=KYOUNG+S.+KIM&rft.date=2006-01-12&rft.externalDBID=A1&rft.externalDocID=AU2005260056A1 |